UTSI Q4 2019 Earnings Significant EPS Miss Sends Stock Down Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline BSRR Q1 2026 Earnings EPS Beats Estimates by 144 Shares Edge Higher RCUS Q1 2026 Earnings WiderthanExpected Loss Highlights Ongoing Biotech Development Costs CRNX Q1 2026 Earnings Narrowed Loss Per Share Slightly Below Expectations Adamas Trust Inc ADAMN Q1 2026 Earnings Preferred EPS Surges Past Estimates Stock Trades Lower